期刊文献+

左旋卡尼汀对老年慢性心力衰竭患者脑钠素、肌钙蛋白I和C反应蛋白的影响 被引量:2

下载PDF
导出
摘要 目的观察左旋卡尼汀治疗老年慢性心力衰竭的疗效及对机体脑钠素(BNP)、心肌肌钙蛋白I(c Tn I)和C反应蛋白(CRP)的影响。方法选择慢性心力衰竭患者80例,随机分为观察组和对照组各40例,对照组予以利尿、扩张血管、血管紧张素抑制剂、α受体阻滞剂等常规治疗,观察组在对照组的基础上予以左旋卡尼汀治疗。观察2组疗效及治疗前后左室舒张末期内径(LVDD)、左室射血分数(LVEF)、每搏量(SV)、心排血量(CO)、CRP、BNP和c Tn I水平变化情况。结果观察组总有效率明显高于对照组(2=4.781,P<0.05)。2组治疗后LVEF、SV和CO水平较治疗前明显提高(P均<0.01),LVDD、CRP、BNP和c Tn I较治疗前明显降低(P均<0.01),而观察组的提高或者降低水平更为明显(P<0.05或P<0.01)。结论左旋卡尼汀治疗老年慢性心力衰竭疗效确切,能够改善患者的心肌耗氧量,减轻机体的炎性反应状态,进一步纠正心肌缺氧、缺血,改善心功能。
出处 《现代中西医结合杂志》 CAS 2015年第5期493-495,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献13

  • 1Pellegrini P, Rossi A, Pasotti M, et al. Prognostic relevance of pul- monary arterial compliance in patients with chronic heart failure [J]. Chest,2014,145(5):1064-1070.
  • 2de Antonio M, Lupon J, Galan A, et al. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I re- garding heart failure risk stratification [ J]. Clin Chim Acta,2013, 426 : 18 - 24.
  • 3Lok DJ,Klip IT,Lok SI,et al. Incremental prognostic power of novel biomarkers (growth-differentiation factor - 15, high-sensitivity C - reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure [ J ~. Am J Cardiol, 2013,112(6):831-837.
  • 4Falk T,Ljungvall I,Zois NE,et al. Cardiac troponin -I concentra- tion, myocardial arteriosclerosis, and fibrosis in dogs with conges- tive heart failure because of myxomatous mitral valve disease[ J]. JVet Intern Med,2013,27(3 ) :500 -506.
  • 5Palazzuoli A, Masson S, Ronco C, et al. Clinical relevance of bio- markers in heart failure and cardiorenal syndrome : the role of natri- uretic peptides and troponin[ J]. Heart Fail Rev,2013,34(4):901 - 9O8.
  • 6Kirk JA, Zhang P, Murphy AM, et al. Troponin I alterations detected by multiple-reaction monitoring:how might this impact the study of heart failure? [ J]. Expert Rev Proteomics,2013,10 ( 1 ) :5 - 8.
  • 7Chang HR, Hsieh JC, Hsu BG, et al. Inverse association of N-termi- nal pro-B-type natriuretie peptide with metabolic syndrome in pa- tients with congestive heart failure [ J ]. PLoS One, 2013,8 ( 11 ) : e79096.
  • 8Hsich EM, Grau-Sepulveda MV, Hernandez AF, et al. Relationship between sex, ejection fraction, and B - type natriuretic peptide lev- els in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline- Heart Failure Registry [ J ]. Am Heart J, 2013,166 ( 6 ) : 1063 - 1071.
  • 9Mcgrady M,Reid CM,Shiel L, et al. NT - proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction:Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)[J]. Int J Cardiol,2013,169(2):133 - 138.
  • 10Troughton R, Michael FG, Januzzi JJ. Natriuretie peptide-guided heart failure management[J]. Eur Heart J,2014,35 (1) :16 -24.

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部